Literature DB >> 3992222

Systemic reactions associated with polyisocyanate exposure.

J Nielsen, C Sangö, G Winroth, T Hallberg, S Skerfving.   

Abstract

A spray-painter suffered attacks of chills, fever, general malaise, dyspnea and wheezing, headache, arthralgia, and leucocytosis a few hours after exposure to aerosols of varnishes containing two different polyisocyanates based upon monomers of hexamethylene or toluene diisocyanate. Immunologic studies revealed an increase in the serum immunoglobulin G level, but no specific antibodies against isocyanates conjugated to human serum albumin. The polyisocyanate level in the workroom air was high [a time-weighted average of 4.2 mg/m3, corresponding to 17 mumol NCO (isocyanate groups)/m3], the toluene diisocyanate monomer level being much lower (a time-weighted average of 0.03 mg/m3, corresponding to 0.3 mumol NCO/m3).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3992222     DOI: 10.5271/sjweh.2253

Source DB:  PubMed          Journal:  Scand J Work Environ Health        ISSN: 0355-3140            Impact factor:   5.024


  4 in total

1.  Biological monitoring of isocyanates and related amines. II. Test chamber exposure of humans to 1,6-hexamethylene diisocyanate (HDI).

Authors:  T Brorson; G Skarping; J Nielsen
Journal:  Int Arch Occup Environ Health       Date:  1990       Impact factor: 3.015

2.  Occupational asthma and extrinsic alveolitis due to isocyanates: current status and perspectives.

Authors:  O Vandenplas; J L Malo; M Saetta; C E Mapp; L M Fabbri
Journal:  Br J Ind Med       Date:  1993-03

3.  Test atmospheres of diisocyanates with special reference to controlled exposure of humans.

Authors:  T Brorson; G Skarping; L Renman; C Sangö
Journal:  Int Arch Occup Environ Health       Date:  1989       Impact factor: 3.015

4.  Test chamber exposure of humans to 1,6-hexamethylene diisocyanate and isophorone diisocyanate.

Authors:  H Tinnerberg; G Skarping; M Dalene; L Hagmar
Journal:  Int Arch Occup Environ Health       Date:  1995       Impact factor: 3.015

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.